Background/Objectives: Weight loss is frequently seen in advanced cancer. Bioelectrical impedance spectroscopy (BIS) is a convenient method for estimating body composition. We examined in a prospective, comparative study if BIS could accurately estimate fat-free mass (FFM) in cancer patients compared to dual-energy X-ray absorptiometry (DXA). Subjects/Methods: The study was based on 132 consecutive incurable cancer patients with solid tumours in a University hospital outpatient clinic. Comparison of FFM from DXA and BIS with standard and revised equations. Bland-Altman plots, t-tests and linear regression analysis were used to evaluate agreement and differences between methods. Results: BIS significantly underestimated mean FFM with 7.6 ± 4.7 kg compared to DXA (Po0.001). Bias was significantly correlated to % weight loss (r ¼ 0.32), systemic inflammation as measured by C-reactive protein (r ¼ 0.29), malnutrition as assessed by low insulin-like growth factor-1 (r ¼ À0.23) and inversely to the per cent body fat estimated by DXA (P ¼ À0.61) and body mass index (BMI; r ¼ À0.30). Revised BIS equations taking BMI into account reduced bias significantly but still with great individual variation. Conclusions: BIS by standard equations grossly underestimates FFM compared to DXA in cancer patients. This bias is related to weight loss, malnutrition and systemic inflammation. Revised equations improved FFM estimates, but with large individual variation. Thus, BIS with standard equations is not suitable to estimate FFM in patients with cachexia, inflammation and malnutrition.
Introduction
Patients with progressive cancer often suffer from weight loss (Barber et al., 1999; Bosaeus et al., 2001) . Although the mechanisms underlying this cachexia are not yet fully understood, systemic inflammation, elevated energy metabolism and insufficient dietary response to elevated energy expenditure may contribute to its development (Barber et al., 1999; Fordy et al., 1999; Bosaeus et al., 2001) . Body composition changes in cancer patients have been reported to be different from those seen in simple starvation and are associated with shortened survival (Barber et al., 1999) . Thus, it is important to assess the body composition in these patients to evaluate nutrition status and response to therapy.
Bioelectrical impedance spectroscopy (BIS) is an indirect but convenient method for estimating body water compartments (De Lorenzo et al., 1997) . BIS measures impedance at a spectrum of frequencies from which the resistances of extracellular (R ECw ) and intracellular (R ICw ) volumes are extrapolated by Cole modelling. From these resistance values the volume of extracellular water (ECW) and intracellular water (ICW) is calculated by mixture equations (De Lorenzo et al., 1997) . BIS and other types of bioelectrical impedance methods were recently subject to an extensive review in two parts (Kyle et al., 2004a, b) .
BIS has been validated as a convenient method for indirect determination of ECW and total body water (TBW) in healthy individuals, by simultaneous determination of these volumes by dilution techniques, (Van Loan et al., 1993; De Lorenzo et al., 1997; Matthie, 2005) . BIS has also been tested in healthy subjects in situations with disturbed water balance, such as experimentally induced hyperhydration and dehydration (Gudivaka et al., 1999) . In patients with disturbed water balance the results are more variable. Thus, agreement between BIS and tracer dilution techniques in the assessment of TBW and ECW in patients on haemodialysis has been reported as unsatisfactory, although the ability to detect changes in ECW was acceptable (Cox-Reijven et al., 2001) . BIS has also been used and validated with dilution methods in patients in a range of clinical situations such as chronic obstructive pulmonary disease (Baarends et al., 1998) , human immunodeficiency virus (HIV)-infected breast feeding mothers (Papathakis et al., 2005) and growth hormone-deficient adults (van Marken Lichtenbelt et al., 1997) where it also correctly assessed the ECW/ICW ratio compared to dilution methods.
BIS may be applied for the estimation of fat-free mass (FFM) particularly in healthy subjects where the fluid content of this compartment and its distribution is stable. The utility of this technique in clinical settings, however, where pathological fluid imbalance and under-or overhydration may be common is questionable. To our knowledge there have been no reports on the applicability of BIS for the determination of FFM in cancer patients. The aim of the present study was thus to investigate if BIS could accurately estimate FFM compared to dual-energy X-ray absorptiometry (DXA) in unselected solid tumour cancer patients.
Methods

Patients and protocol
This study was based on cancer patients who underwent measurements of body composition at the Department of Surgery, Sahlgrenska University Hospital and formed part of an ongoing study on incurable cancer patients approved by the Ethic Committee of the University of Göteborg. In total, 132 patients with solid tumours were included (Table 1) . None of the patients had clinical signs of oedema. All patients were considered as inoperable. None of them received any specific cancer treatment. The majority of patients presented with gastrointestinal tumours (Table 2) .
Patients attended the laboratory after an overnight fast (water only allowed) where height was measured to the nearest cm and body weight was measured to the nearest 0.1 kg on a digital Sartorius scale (Carl Lidén AB, Sweden).
Dual-energy X-ray absorptiometry DXA was performed using a LUNAR DPX-L scanner for the first 45 patients, and a LUNAR PRODIGY-scanner for the latter 87 patients (Scanex, Helsingborg, Sweden). Whole-body scans were performed and body fat (BF), lean soft tissue (LST) and bone mineral content (BMC) were analysed (software versions 1.31 and 3.60.031, respectively, extended research analysis mode). FFM by DXA (FFM DXA ) was defined as LST þ BMC.
Bioelectric impedance spectroscopy
Bioimpedance analysis was carried out using a Xitron Hydra 4200 device (Xitron Technologies, San Diego, USA) . The subjects rested in the supine position for 5 min before the tetrapolar whole-body measurement with electrodes on the dorsal surface of the right hand/wrist and at the right foot/ ankle according to the manufacturer's instructions (Xitron, 1997) . All measurements were done in duplicate, and the mean value was used. ECW BIS and ICW BIS were calculated from the Hanai equation (Xitron, 1997; Matthie, 2005) : (Xitron, 1997 ). Furthermore, we tested the ability of a new set of equations based on measurements by Xitron Hydra in both healthy subjects and renal patients, validated by isotope dilution (tritium and bromide) and by whole-body counting (total body potassium, TBK) (Moissl et al., 2006) . With this approach, termed body composition spectroscopy (BCS) the parameters r ECW , r ICW , K B and density (D) are combined into two parameters k ECW and k ICW to yield two BCS equations for ECW BCS and ICW BCS :
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where R I is intracellular resistance and k ECW and k ICW are functions of body mass index (BMI):
The parameters were determined as a ¼ 0.188, b ¼ 0.2883, c ¼ 5.8758 and d ¼ 0.4194 by cross-validation (Moissl et al., 2006) . ECW BCS and ICW BCS were converted to FFM BCS by Equation (4). Fat-free mass (FFM TBWBIS ) was also estimated directly from TBW, calculated as the sum of ECW and ICW, based on the assumption of a 73% hydration of the fat-free mass (Ellis, 2000) .
Statistical analysis SPSS 12.0.1 for Windows (SPSS Inc., Chicago, IL, USA) was used for statistical analyses. Descriptive statistics are reported as means with s.d. and range. Bland-Altman plots were used to compare FFM estimates by DXA and BIS. The limits of agreement between the two methods were defined as mean difference ± 2 s.d. (Altman, 1991) . Independent samples t-test was used to test differences between the first and second group of patients scanned by DPX-L or PRODIGY, respectively. Paired t-test was used to compare FFM by DXA to FFM as estimated by other equations. Predictors for the association between the difference in FFM from DXA and BIS were analysed by linear regression. Serum levels of C-reactive protein (CRP) were found to be non-normally distributed, and were log transformed before analysis.
Results
There were no differences in body weight, BMI, gender, age, ECW/ICW ratio or serum CRP levels in the first 45 patients scanned by LUNAR DPX-L compared to the 87 patients scanned by LUNAR PRODIGY (data not shown). For comparison, 15 subjects were measured during the same day on both scanners and there was no significant bias between the FFM from Lunar Prodigy vs Lunar DPX-L (mean bias, 0.19±0.83 kg; P ¼ 0.34). In addition, there was no significant difference (P ¼ 0.76) in the bias of FFM BIS vs FFM DXA(DPX) (mean bias, 7.85 ± 5.35 kg) compared to FFM BIS Table 3 . Differences between DXA and the bioimpedance methods are shown in Table 4 .
Mean weight loss from pre-morbid weight was 9.7 kg ranging from maximum loss of 37.6 kg to a gain of 9.9 kg (Po0.001). Regression analysis of the BIS variables R ICW , R ECW and C m on FFM DXA showed a correlation coefficient of 0.76 and a regression coefficient of 0.57, with a standard error of estimate of 6.94.
FFM comparison BIS
BIS significantly underestimated mean FFM as shown in Table 4 and in Figure 1a . The underestimation was more pronounced in men than in women (8.7 ± 4.9 vs 5.7 ± 3.8 kg, P ¼ 0.045), and more pronounced in 19 patients with BMIo19 (10.8±4.0 kg) vs 113 patients with BMI419 (7.12 ± 4.7 kg, P ¼ 0.001), and also more pronounced in patients with weight loss greater than 5%, (8.2 ± 4.6 vs 5.7±4.9 kg, P ¼ 0.014). Differences between FFM BIS and FFM DXA were significantly correlated with the ECW/ICW ratio ( Figure 2 ) and 50-kHz phase angle, and also correlated with both % weight loss, low fat mass index (FMI), inflammation as determined by log serum CRP values, and deteriorated nutritional status assessed by low serum levels of insulin-like growth factor (IGF-1) as shown in Table 5 . The correlation was less strong for FFM index (FFMI). Patients with ECW/ICW ratios above median value 1.06 were on average 4.5 years older, had lost 5% units more weight, had 1.0 kg/m 2 lower FMI, 14 mg/l lower levels of IGF-1 and 2.1 g/l lower albumin levels, whereas BMI, FFMI, CRP-levels or gender did not differ between the two halves. As can be inferred from Figure 2 , the difference in FFM was much more pronounced in the group with higher ECW/ICW ratios, but this was caused solely by a significantly 3.9 kg lower ICW, whereas ECW did not differ between the groups.
FFM comparison by BIS BCS FFM calculated from BCS equations (FFM BCS ) (Figure 1b)
showed the least bias of all equations compared to FFM DXA .
Estimates of FFM by the BCS equation were still significantly different from FFM DXA (Po0.001).
FFM TBWBIS compared to FFM DXA FFM TBWBIS (Figure 1c ) calculated from TBW BIS /0.73 significantly underestimated mean FFM.
Discussion
We have compared an easy bed-side body composition method with a more expensive and non-portable method to estimate fat-free mass in cancer patients. Unfortunately, this study in incurable cancer patients shows BIS with standard equations to grossly underestimate FFM compared to DXA. The difference was highly correlated to the ECW/ ICW ratio, driven by an increasing underestimation of ICW, and phase angle as estimated by BIS, to low per cent BF assessed by DXA, and also to weight loss, malnutrition and systemic inflammation. FFM estimate calculated from TBW by BIS was closer to FFM from DXA. The best, although still Abbreviations: BCS, body composition spectroscopy; BIS, bioelectrical impedance spectroscopy; DXA, dual-energy X-ray absorptiometry; FFM, fat-free mass; TBW, total body water. FFM DXA , estimated from bone mineral þ lean soft tissue by DXA. FFM BIS , estimated by original equations for Xitron Hydra (Xitron, 1997; Matthie, 2005) . FFM BCS , estimated by equations from BCS (Moissl et al., 2006) . FFM TBWBIS , estimated from TBW by BIS divided by 0.73 (Ellis, 2000 
DXA in body composition
DXA has been used extensively during the last decade for body composition purposes because of its speed and precision for the assessment of BF and fat-free mass (BMC þ LST) (Jebb, 1997; Ellis, 2000) . FFM derived from DXA measurements correlates well with FFM determined by hydrodensitometry and TBK measurements in healthy adults (Jebb, 1997) . DXA has also been demonstrated to give accurate estimates of FFM compared to dilution methods or TBK in patients with inflammatory bowel disease considered malnourished with a mean BMI of 20.3 (Royall et al., 1994) , in wasted HIV-patients (Corcoran et al., 2000) , and in underweight patients with various gastrointestinal disorders (Haderslev and Staun, 2000) . However, DXA has also been reported to have a tendency to progressively underestimate BF, and thus overestimate FFM, in leaner healthy subjects compared to hydrodensiometry and dilution 
FFM difference (DXA-BIS) kg
Figure 2 Fat-free mass (FFM) differences between dual-energy X-ray absorptiometry (DXA) and bioelectrical impedance spectroscopy (BIS) compared with extracellular water (ECW)/intracellular water (ICW) ratio in 132 incurable cancer patients (r ¼ 0.65, Po0.001). Abbreviations: BMI, body mass index; CRP, C-reactive protein; DXA, dualenergy X-ray absorptiometry; FFMI, fat-free mass index; FMI, fat mass index; IGF-I, insulin-like growth factor 1; SEE, standard error of the estimate; WL, weight loss. FMI, body fat as estimated by DXA/height 2 . IGF-1, serum levels of insulin-like growth factor 1. Log CRP, log-transformed value of C-reactive protein concentration in serum. Albumin, serum levels of albumin. BMI, body weight/height 2 . FFMI, fat-free mass as estimated by DXA/height 2 . % WL, percent weight loss compared to pre-morbid weight. methods (Van Der Ploeg et al., 2003) . DXA is thus an increasingly used method for body composition analysis, although the equipment is expensive and not without some disadvantages. Most important from a clinical view is the fact that DXA cannot measure over-or underhydration, nor does it distinguish between intracellular and extracellular water (Plank and Hill, 2001) .
BIS in body composition
The BIS technique is used increasingly as it is inexpensive, easy and quick to perform, portable and correlates well with other methods in healthy adults. However, resistance values obtained from BIS measurements must be validated against more direct methods of body composition (Ellis, 2000) . This has been accomplished in healthy subjects (Van Loan et al., 1993; De Lorenzo et al., 1997; Gudivaka et al., 1999; Soldervik, 2005; Ward et al., 2007) and in patients without major disturbances in body water distribution (van Marken Lichtenbelt et al., 1997; Baarends et al., 1998; Papathakis et al., 2005) .
BIS was found to overestimate FFM compared to DXA in well-nourished stable patients with ileostomy and inflammatory bowel disease (Carlsson et al., 2002) , and in patients with short bowel syndrome (Carlsson et al., 2004) . BIS has been successfully used for evaluation of ECW and TBW during pregnancy (Van Loan et al., 1995) , and recently BIS was found to produce accurate but imprecise estimations of both ECW, ICW and TBW before pregnancy, in early pregnancy and postpartum, whereas ECW and TBW were underestimated during late pregnancy (Lof and Forsum, 2004) . Lately the BIS calculations have been improved by taking BMI into account in a technique termed body composition (Moissl et al., 2006) , recently supported by other investigators (Ward et al., 2007) .
Body composition in cancer patients
The majority of our patients had gastrointestinal cancer. Weight loss in cancer patients is common, being seen in the majority of patients with gastric, pancreatic, lung, prostate and colon cancer (Barber et al., 1999) .
BIS using manufacturer's software, underestimated FFM by 7.6 kg corresponding to 15% compared to DXA in our cancer patients. The bias was strongly correlated to the ECW/ICW ratio, and this ratio at 1.08 was on average higher than in healthy subjects. Some patients were annotated ECW/ICW ratios up to 1.7, even without showing any signs of oedema, thus raising suspicion on the accuracy of BIS to truly reflect different water compartments in cancer patients. This is in line with data reported by Cox-Reijven et al. (2003) in a population dominated by gastrointestinal cancer patients where the underestimation of TBW by BIS compared to TBW by dilution (and thus of FFM) gradually increased from 1.8 kg over 2.8-3.9 kg in three groups selected according to no, minor or major weight loss, where ECW/ICW ratios by BIS were 1.18, 1.24 and 1.32, respectively, all driven by underestimation of ICW. Hence, BIS bias increased with greater weight loss, due to apparently decreasing ICW values which did not correspond to dilution data. Furthermore, in our experience, the 50% of patients with highest ECW/ICW ratios also showed significant lower values on ICW compared to the half with lower ECW/ICW ratios, whereas there were no differences in ECW. In addition, in our experience we have found the insignificant bias of 0.2 kg between FFM BIS and FFM DXA still to be correlated (r 2 ¼ 0.21) to the ECW/ICW ratio in 42 healthy subjects aged 20-86, with BMI ranging from 19 to 35 where ECW/ICW by BIS was not significantly different from ECW/ICW by dilution methods (Soldervik, 2005) . The constants d ECW and d ICW , applied for the mean density of ECW and ICW as applied in the BIS Xitron Hydra software are based on the assumption that FFM is composed of 6.8% bone and 73.8% water (44.3% ICW and 29.5% ECW) (Xitron, 1997) . These assumptions may not be accurate in weight losing cancer patients, as the mean ECW/ICW ratio as estimated from the original BIS equation was 1.08 and not 29.5/44.3 ¼ 0.66 as assumed in the software. Hence, BIS underestimates ICW in situations with weight loss, malnutrition and systemic inflammation. In fact, we found estimation of FFM directly from TBW by BIS, without other assumptions than the constant 73% hydration of the FFM, to be significantly less biased than the standard BIS procedure.
Many weight-losing cancer patients have systemic inflammation and elevated energy expenditure (Bosaeus et al., 2001) , and systemic inflammation might affect water distribution with a relative expansion of ECW (Plank and Hill, 2001) . Thus, it is not surprising that the underestimation by FFM BIS was strongly correlated with the ECW/ICW ratio, as well as to the degree of emaciation expressed as low per cent BF, low serum levels of IGF-1 and to systemic inflammation.
Conclusion
BIS by standard equations grossly underestimate FFM compared to DXA in malnourished incurable cancer patients. This bias was apparently produced by increasingly underestimation of ICW and was related to relative weight loss, (especially loss of fat), systemic inflammation and malnutrition. FFM estimation from TBW measured by BIS reduced the bias, and a new BIS equation titled BCS taking BMI into account, reduced bias by 35%. Thus, BIS with standard equations is not suitable for FFM estimation in patient groups with weight loss, malnutrition, inflammation and cachexia. For such situations BIS equations need to be carefully checked against reference methods.
